Jefferies recommends high-dividend, low-volatility stocks to navigate current market turbulence. Analyst Desh Peramunetilleke suggests that companies like Procter & Gamble, Pfizer, Simon Property Group, and KeyCorp offer a blend of income and stability amid concerns in the AI sector and broader market uncertainties.
In a choppy market environment, investors are seeking refuge in stocks that offer both income and stability. Jefferies suggests that high-dividend, low-volatility stocks could be the key to protecting portfolios from market swings.

While major indexes have seen gains this year, the journey has been far from smooth. Geopolitical tensions, fluctuating oil prices, inflation, and the meteoric rise and subsequent volatility of AI stocks have kept investors on edge. Desh Peramunetilleke, an analyst at Jefferies, noted that the AI theme, while a long-term winner, is experiencing headwinds due to concerns about hyperscaler ROI, inflated expectations, and significant retail positioning.
As an alternative, Peramunetilleke highlights low-volatility stocks with high dividend or free-cash-flow yields as a strategic play for the summer. These selections can act as a hedge against potential sharp market corrections if AI-related concerns escalate. Jefferies screened for U.S. companies with a market capitalization exceeding $10 billion, ranking in the bottom quintile for volatility. These companies also needed to demonstrate a forward dividend yield above 3% or a free cash flow yield above 3% over the past 12 months, with positive or flat estimated earnings-per-share revisions for 2026 in the last three months.
Among the recommendations is Procter & Gamble (PG), a consumer staples giant offering a 3% forward dividend yield. The company recently reported strong fiscal fourth-quarter results, with both earnings per share and revenue exceeding expectations, driven by increased product volumes. Analysts favor PG, assigning it an average 'overweight' rating and projecting a 10% upside potential.

Another stock on the list is Pfizer (PFE), which offers a substantial 6.9% forward dividend yield, despite being down approximately 2% year-to-date. The pharmaceutical company recently received FDA approval for its Padcev and Keytruda combination for muscle-invasive bladder cancer. While it also faced a setback with an experimental lung cancer drug trial, analysts maintain an average 'hold' rating with a 16% upside potential.
Simon Property Group (SPG), a prominent mall operator, stands out with a 4.30% forward dividend yield and an 18% year-to-date gain. The company reported strong second-quarter results, exceeding expectations for funds from operations and raising its full-year guidance and quarterly dividend. CEO Eli Simon highlighted strong operating performance driven by leasing momentum and increased retailer sales and traffic.

Finally, KeyCorp (KEY), a financial services provider, offers a 3.8% forward dividend yield and has seen a 12% increase year-to-date. The company also beat first-quarter earnings and revenue estimates, and analysts are bullish, with an average 'overweight' rating and a 7.5% upside potential.
